Plus Therapeutics Files 8-K: Officer Changes and Compensation Details

Ticker: PSTV · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001095981

Plus Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyPlus Therapeutics, Inc. (PSTV)
Form Type8-K
Filed DateApr 9, 2026
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: officer-change, compensation, corporate-governance

TL;DR

PLUS THERAPEUTICS made officer changes and filed compensation details. Watch for new leadership impact.

AI Summary

On April 8, 2026, PLUS THERAPEUTICS, INC. filed an 8-K report detailing the departure of a director and the appointment of a new officer. The filing also includes information on compensatory arrangements for certain officers, though specific dollar amounts and names of individuals involved in these arrangements are not detailed in the provided text.

Why It Matters

Changes in corporate officers and details about their compensation can signal shifts in company strategy or financial priorities, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Officer departures and appointments, along with compensation disclosures, can indicate internal shifts that may affect the company's future direction and stability.

Key Players & Entities

  • PLUS THERAPEUTICS, INC. (company) — Filer of the 8-K report
  • 0001095981 (company) — CIK number for PLUS THERAPEUTICS, INC.
  • 2026-04-08 (date) — Period of Report for the 8-K filing
  • 2026-04-09 (date) — Filing Date and Acceptance Date of the 8-K report

FAQ

Who departed from PLUS THERAPEUTICS, INC. as a director?

The filing indicates the departure of a director, but the specific name is not provided in the summary text.

Who was appointed as a new officer at PLUS THERAPEUTICS, INC.?

The filing mentions the appointment of a certain officer, but the specific name and title are not detailed in the provided text.

What specific compensatory arrangements are detailed for officers?

The filing notes that compensatory arrangements of certain officers are included, but the specific details and dollar amounts are not elaborated in the provided text.

What is the CIK number for PLUS THERAPEUTICS, INC.?

The CIK number for PLUS THERAPEUTICS, INC. is 0001095981.

What is the filing date of this 8-K report?

The 8-K report was filed and accepted on April 9, 2026.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding PLUS THERAPEUTICS, INC. (PSTV).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.